Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Clinical trial NCT05951179 · RECRUITING
Trial details
- NCT number
- NCT05951179
- Sponsor
- Protara Therapeutics
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-15
- Primary completion
- 2031-10-01
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.